CSL takes the wraps off a big new R&D cen­ter as it eyes vac­cines, cell and gene ther­a­pies

CSL may still be best known as one of the world’s largest plas­ma providers, but as the Aus­tralian play­er opens a new R&D hub in Mar­burg, Ger­many, it’s hop­ing to make its name in a whole lot more.

Al­most three years af­ter start­ing con­struc­tion, CSL an­nounced its M600 R&D cen­ter — which cost about €150 mil­lion — will be com­plet­ed lat­er this year. On top of labs and work­space, the com­pa­ny is carv­ing out some room for star­tups from the re­gion.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER